About us_上海瀚枢生物医药有限公司

About us
Company Introduction

Kylin Lab is a preclinical CRO company specializing in central nervous system (CNS) diseases, dedicated to offering one stop solutions for CNS drug discovery. With a portfolio of fully-validated cellular and animal disease models, combined with comprehensive research and analytical capabilities, we empower clients to accelerate the development of innovative therapies and reduce clinical trial risks.

Our technical team is highly experienced, familiar with international regulations, and conducts their work based on high-standard experimental platforms. Our core technologies include AI-driven phenotypic screening, humanized stem cells and organoids, electrophysiology, high-throughput electroencephalography (EEG), histology, and molecular biology. Our expertise spans a broad range of areas including Alzheimer’s disease, Parkinson’s disease, depression, schizophrenia, spinal muscular atrophy (SMA), pain, stroke,etc.

Since its establishment, we have steadfastly upheld the principle of "Pioneering in R&D, Leading in Technology, Prioritizing Quality, First Customer."To date, we have served over a hundred clients, successfully completed numerous specialized research projects and IND applications, and established a high-quality, robust, and forward-looking efficacy evaluation system.

70 70

+
Disease Models

100 100

+
Evaluation Paradigm

100 100

+
Our Partner
Mission
Advancing high-quality translational research

to enable breakthrough CNS therapies

Vision
Accelerating the Birth of Innovative Medicines,

Advancing More High-Quality Treatments to

Patients

Core Values
Pioneering in R&D, Leading in Technology,

Prioritizing Quality, First Customer

Company Introduction
Featuring AAALAC-accredited animal facility, specialized behavioral testing laboratories, and a multifunctional surgical & imaging platform.
History
2025

• Awarded "Shanghai Specialized, Refined, Unique and Innovative SME" status

2024

• Attained AAALAC Accreditation
• Commenced Global Business Expansion

2023

• Certified as "Shanghai Technology-based SME"
• Recognized as "Shanghai High-tech Enterprise"

2022

• Closed Angel-round Financing
• Commissioned 1,500+ m² SPF Animal Facility

2021

• Shanghai Kylinlab Biopartner Co., Ltd. was officially established

2025

2024

2023

2022

2021
Focus Area
Focus Area
Kylin Lab focuses on the CNS area,precisely identify and address client needs in CNS drug development, ensuring our solutions are closely aligned with real R&D scenarios.
Cutting-Edge Technology
Cutting-Edge Technology
Kylin Lab possesses internationally leading capabilities in animal model development, cell-based screening system, electrophysiology platform, AI-driven phenotypic screening platform, and stem cell/organoid models. These advanced technologies significantly enhance the efficiency of disease modeling and mechanism studies, target screening and optimization, efficacy assessment and prediction, as well as safety evaluation.
Crack Team
Crack Team
The team possesses profound expertise in CNS disease research and keen insight into global drug regulatory policies, providing comprehensive support across the entire development pipeline from target discovery to clinical translation.
Efficient Delivery
Efficient Delivery
Leveraging profound R&D expertise and extensive practical experience, we precisely align with client needs to deliver customized R&D solutions. Through our innovative "CRO+" service model, we ensure efficient project execution and comprehensively accelerate the R&D process of drug.
International Standard
International Standard
We have established a quality management system that complies with international standards and a high-quality laboratory base.
Specialized Facilities
Specialized Facilities
We possess SPF-grade animal housing and professional R&D laboratories, with advanced hardware to support cutting-edge scientific research and technological development.
Qualifications &Awards
Shanghai High-tech Enterprise
Shanghai Technology-based SME Certificate
Laboratory Animal Production License
AAALAC Accreditation
Our Partner